Summit Partners Public Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-11,287
Closed -$455K – 103
2020
Q4
$455K Sell
11,287
-17,043
-60% -$783K 0.02% 83
2020
Q3
$1.57M Buy
+28,330
New +$1.5M 0.08% 81

Other funds holding GDRX

Summit Partners Public Asset Management's GDRX Position: Q1 2021 in Review

Summit Partners Public Asset Management sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 11,287 shares — an estimated $455K sold.

Summit Partners Public Asset Management first reported a position in GDRX in Q3 2020 and held it in 2 quarters. The position peaked at $1.57M in Q3 2020. 206 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

  • Summit Partners Public Asset Management reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
  • Summit Partners Public Asset Management sold 11,287 GoodRx Holdings shares in Q1 2021, an estimated $455K.
  • Summit Partners Public Asset Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 2 quarters.
  • Summit Partners Public Asset Management's GoodRx Holdings position peaked at $1.57M in Q3 2020.
  • 206 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on Summit Partners Public Asset Management's 13F filing for Q1 2021, filed 17 May 2021.